精华制药
(002349)
| 流通市值：60.58亿 | | | 总市值：61.73亿 |
| 流通股本：8.14亿 | | | 总股本：8.30亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 723,772,620.78 | 794,716,319.33 | 995,477,816.13 | 1,013,590,836.03 |
| 交易性金融资产 | 462,589,373.74 | 290,556,068.67 | 187,928,957.15 | 105,158,832.09 |
| 应收票据及应收账款 | 353,607,239.45 | 368,541,173.34 | 354,439,675.02 | 334,820,669.36 |
| 其中：应收票据 | 38,329,477.69 | 45,347,193.23 | 42,536,200.18 | 43,989,807.27 |
| 应收账款 | 315,277,761.76 | 323,193,980.11 | 311,903,474.84 | 290,830,862.09 |
| 应收款项融资 | 81,086,534.51 | 83,847,105.22 | 72,334,458.6 | 79,762,201.2 |
| 预付款项 | 14,680,799.38 | 17,172,361.81 | 13,141,877.63 | 6,671,617.99 |
| 其他应收款合计 | 1,311,208.79 | 2,657,203.71 | 2,592,729.59 | 2,679,074.71 |
| 存货 | 285,467,044.89 | 281,607,118.87 | 272,415,011.09 | 270,345,771.69 |
| 其他流动资产 | 1,245,712.79 | 761,100.89 | 572,779.57 | 459,443.8 |
| 流动资产合计 | 1,954,574,731.1 | 1,870,672,648.61 | 1,929,717,501.55 | 1,844,302,643.64 |
| 非流动资产: | | | | |
| 投资性房地产 | 241,235,369.04 | 243,507,225.88 | 245,784,134.86 | 248,061,043.84 |
| 固定资产 | 543,657,836.25 | 557,796,217.27 | 574,618,007.25 | 561,674,329.88 |
| 在建工程 | 37,328,257.35 | 33,721,205.19 | 31,726,810.54 | 53,569,031.43 |
| 使用权资产 | 972,153.14 | 492,424.95 | 638,894.06 | 1,134,752.01 |
| 无形资产 | 59,197,343.97 | 59,717,774.1 | 60,253,892.35 | 60,517,268.51 |
| 商誉 | 167,944,061.4 | 167,944,061.4 | 167,944,061.4 | 167,944,061.4 |
| 递延所得税资产 | 6,509,172.7 | 6,004,686.49 | 5,914,908.23 | 5,980,983.26 |
| 其他非流动资产 | 476,428,940.03 | 484,727,852.89 | 359,297,371.39 | 358,595,663.17 |
| 非流动资产合计 | 1,533,273,133.88 | 1,553,911,448.17 | 1,446,178,080.08 | 1,457,477,133.5 |
| 资产总计 | 3,487,847,864.98 | 3,424,584,096.78 | 3,375,895,581.63 | 3,301,779,777.14 |
| 流动负债: | | | | |
| 短期借款 | - | 8,296 | 10,006,936.11 | 10,426,936.11 |
| 应付票据及应付账款 | 150,179,848.82 | 161,649,569.81 | 165,414,435.73 | 148,438,239.29 |
| 其中：应付票据 | 9,450,800 | 13,720,800 | 12,888,200 | 6,758,200 |
| 应付账款 | 140,729,048.82 | 147,928,769.81 | 152,526,235.73 | 141,680,039.29 |
| 合同负债 | 13,840,143.66 | 17,042,481.65 | 12,662,407.57 | 11,441,558.92 |
| 应付职工薪酬 | 48,779,085.73 | 44,747,217.3 | 51,063,540.69 | 62,770,633.67 |
| 应交税费 | 23,189,952.86 | 24,291,512.41 | 26,209,510.8 | 22,166,258.28 |
| 其他应付款合计 | 114,738,732.06 | 103,585,129.98 | 39,667,748.2 | 51,977,093.31 |
| 一年内到期的非流动负债 | 187,823.53 | 60,420.69 | 337,363.23 | 750,887.86 |
| 其他流动负债 | 23,010,748.2 | 23,555,280.09 | 20,362,398.34 | 17,611,812.14 |
| 流动负债合计 | 373,926,334.86 | 374,939,907.93 | 325,724,340.67 | 325,583,419.58 |
| 非流动负债: | | | | |
| 租赁负债 | 621,957.61 | 143,842.04 | 242,701.56 | 199,403.33 |
| 递延收益 | 11,026,977.19 | 11,230,403.17 | 11,433,829.15 | 11,637,255.12 |
| 递延所得税负债 | 7,841,703.85 | 7,504,199.92 | 7,554,883.26 | 7,146,303.52 |
| 其他非流动负债 | 87,494.22 | 87,494.22 | 89,894.22 | 89,894.22 |
| 非流动负债合计 | 19,578,132.87 | 18,965,939.35 | 19,321,308.19 | 19,072,856.19 |
| 负债合计 | 393,504,467.73 | 393,905,847.28 | 345,045,648.86 | 344,656,275.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 829,674,908 | 829,674,908 | 814,180,908 | 814,180,908 |
| 资本公积 | 818,498,240.92 | 813,530,477.15 | 769,004,594.63 | 769,004,594.63 |
| 减:库存股 | 56,708,040 | 56,708,040 | - | - |
| 专项储备 | 8,438,012.88 | 7,841,561.08 | 6,893,089.35 | 5,304,333.46 |
| 盈余公积 | 130,131,556.33 | 130,131,556.33 | 130,131,556.33 | 130,131,556.33 |
| 未分配利润 | 976,114,659.81 | 930,386,399.38 | 927,095,764.42 | 864,876,074.03 |
| 归属于母公司股东权益合计 | 2,706,149,337.94 | 2,654,856,861.94 | 2,647,305,912.73 | 2,583,497,466.45 |
| 少数股东权益 | 388,194,059.31 | 375,821,387.56 | 383,544,020.04 | 373,626,034.92 |
| 股东权益合计 | 3,094,343,397.25 | 3,030,678,249.5 | 3,030,849,932.77 | 2,957,123,501.37 |
| 负债和股东权益合计 | 3,487,847,864.98 | 3,424,584,096.78 | 3,375,895,581.63 | 3,301,779,777.14 |
| 公告日期 | 2025-10-30 | 2025-08-30 | 2025-04-30 | 2025-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |